Stemtech (STEK) Equity Average (2013 - 2025)

Stemtech has disclosed Equity Average across 13 years of filings, most recently posting -$6.8 million for Q4 2025.

• Equity Average for Q4 2025 came in at -$6.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$6.8 million (changed N/A YoY), and the FY2025 annual result was -$6.5 million, down 61.53% from the prior year.
• Equity Average came in at -$6.8 million for Q4 2025 at Stemtech, down from -$5.8 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $332077.0 in Q1 2021 to a low of -$16.7 million in Q3 2022.
• The 5-year median for Equity Average is -$4.2 million (2021), against an average of -$5.1 million.
• Across the five-year window, Equity Average tumbled 5250.53% in 2022 and jumped 86.12% in 2023, its largest moves.
• Stemtech's Equity Average stood at -$4.2 million in 2021, then grew by 6.52% to -$3.9 million in 2022, then surged by 52.64% to -$1.9 million in 2023, then plunged by 131.09% to -$4.3 million in 2024, then plunged by 56.44% to -$6.8 million in 2025.
• The last three Equity Average figures came in at -$6.8 million (Q4 2025), -$5.8 million (Q3 2025), and -$5.7 million (Q2 2025), per Business Quant data.